Renal tubular alteration by crystalluria in stone disease - An experimental study by means of MDCK cells

Urologia Internationalis

Volumn 72, Issue 3, 2004, Pages 244-251

  Lahme, S ^a   Feil, G ^a   Strohmaier, W L ^a   Bichler, K H ^a   Stenzl, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Crystallization; Renal tubulus; Stone formation; Urolithiasis

Indexed keywords

ALLOPURINOL; CALCIUM; COLECALCIFEROL; OXALIC ACID; PARATHYROID HORMONE; SELENIUM; WHEWELLITE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; CRYSTALLURIA; CYTOPATHOGENIC EFFECT; DRUG EFFECT; KIDNEY CELL CULTURE; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; NEPHROTOXICITY; NONHUMAN; PH; PRIORITY JOURNAL; UROLITHIASIS;

ANIMALS; CRYSTALLIZATION; DOGS; KIDNEY TUBULES; URINARY CALCULI;

EID: 1842829937     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077124     Document Type: Article

References (47)

1. Vermeulen CW, Lyon ES: Mechanisms of genesis and growth of calculi. Am J Med 1968;45:684.
2. Koch FE: Experimentelle Untersuchungen über die Nierensteinbildung. Z Urol Sonderheft 1950;1:110.
3. Finlayson B, Reid F: The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978;15:442.
4. Robertson WG, Peacock M, Marshal RW, Nordin BEC: Saturation-inhibitor index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 1976;294:249.
5. Randall A: Papillary pathology for the origin of renal calculus. N Engl J Med 1940;214:234.
6. Cifuentes Delatte L, Minon-Cifuentes JLR, Medina JA: Papillary stones: Calcified renal tubules in Randall's plaques. J Urol 1985;133:490.
7. Harrison DJ, Inglis JA, Tolley DA: Percutaneous renal biopsy specimens in stone formers. J Clin Pathol 1988;41:971-974.
8. Baggio B, Gambaro G, Ossi E, Favaro S, Borsatti A: Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 1983;129:1161.
9. Caulfield JB, Schrag PE: Electron microscopic study of renal calcifications. Am J Pathol 1964;44:365-381.
10. Scarpelli DG: Experimental nephrocalcinosis. Lab Invest 1965;14:123.
11. Farber JL: The role of calcium in cell death. Life Sci 1981;29:1289.
12. Browning MC: Effect of verapamil on cephaloridine nephrotoxicity in anesthesized rats. Toxicol Appl Pharmacol 1990;103:383.
13. Iaina A, Herzog D, Cohen D, Gevendo S, Kapuler S, Serban I, Schiby G, Eliahou HE: Calcium entry blockade with verapamil in cyclosporine A plus ischemia induced renal failure in rats. Clin Nephrol 1986;25(suppl):168.
14. Bichler KH, Henzler B, Strohmaier WL, Stahl C, Korn S: Die Bedeutung von Zitrat, Uromucoid und GAG für die Diagnostik der renalen tubulären Azidose bei Harnsteinpatienten. Urologe A 1995;34:437-443.
15. Scarpelli DJ: Experimental nephrocalcinosis. Lab Invest 1965;14:123.
16. Strohmaier Wl: Nierenfunktionsstörungen und Renoprotektion bei Urolithiasis und extrakorporaler Stosswellenlithotripsie; post-doctoral thesis, Tübingen 1991.
17. Caulfield JB, Schrag PE: Electron microscopy study of renal calcification. Am J Pathol 1964;44:365.
18. Strohmaier WL, Seeger RD, Osswald H, Bichler KH: Renal insufficiency induced by parathyroid hormone: Influence of the calcium antagonist Gö 6070. Eur Urol 1992;21:323.
19. Khan SR, Hackett RL: Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature. Scanning Electron Microsc 1985;11:759.
20. Khan SR, Finlayson B, Hackett RL: Histologic study of the early events in oxalate crystal induced intranephronic calculosis. Invest Urol 1979;17:199.
21. Khan SR, Finlayson B, Hackett RL: Experimental induction of crystalluria in rats using mini-osmotic pumps. Urol Res 1983;11:199.
22. Khan SR, Finlayson B, Hackett RL: Scanning electron microscopy of calcium oxalate crystal formation in experimental nephrolithiasis. Lab Invest 1979;41:504.
23. Khan SR, Finlayson B, Hackett RL: Experimental calcium oxalate nephrolithiasis in the rat, role of the renal papilla. Am J Pathol 1982;107:59.
24. Dieppe PA: Crystal deposition and inflammation. Q J Med 1984;211:309.
25. Hasselbacher P: Stimulation of synovial fibroblasts by calcium oxalate and monosodium urate monohydrate. J Lab Clin Med 1982;100:977.
26. Wiessner JH, Mandel GS, Mandel NS: Interaction with calcium oxalate crystals. Variation in hemolytic potential with crystal morphology. J Urol 1986;135:835.
27. Kageyama S, Ohtawara Y, Fujita K, Watanabe T, Ushiyama T, Suzuki K, Naito Y, Kawabe K: Microlith formation in vitro by Madin-Darby canine kidney cells. Int J Urol 1996;3:23-26.
28. Gaush CR, Hard WL, Smith TF: Characterization of an established line of canine kidney cells. Proc Soc Exp Biol Med 1966;122:931-935.
29. Legrand C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, Duval D, Hache J: Lactate dehydrogenase activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. J Biotechnol 1992;25:231-243.
30. Verkoelen CF, Romijn JC, Bruijn WC, Boevé ER, Cao LC, Schröder FH: Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney Int 1995;48:129-138.
31. Strohmaier WL, Bichler KH, Gaiser I, Schulze E, Nelde HJ, Schreiber M: Urine and serum biochemistry relative to the risk of lithogenesis in rats on atherogenic diet; in Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds): Urolithiasis and Related Clinical Research. New York, Plenum Press, 1985, p 941.
32. Nelde HJ, Bichler KH, Strohmaier WL: Histopathological changes in the kidney of the rat on an atherogenic diet; in Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds): Urolithiasis and Related Clinical Research. New York, Plenum Press, 1985, p 945.
33. Nelde HJ, Bichler KH, Strohmaier WL, Kriz W: Nephrocalcinosis in the kidney of the rat on atherogenic diet and the effect of calcium antagonists (nifedipine); in Bichler KH, Strohmaier WL (eds): Nephrocalcinosis, Calcium Antagonists and Kidney. Berlin, Springer, 1988, p 113.
34. Bigelow MW, Wiessner JH, Kleinman JG, Mandel NS: Calcium oxalate crystal attachment to cultured kidney epithelial cell lines. J Urol 1998;160:1528-1532.
35. Hackett RL, Shevock PN, Khan SR: Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 1994;22:197-204.
36. Lieske JC, Leonard R, Toback FG: Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 1995;268:F604-F612.
37. Hackett RL, Shevock PN, Khan SR: Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals. Scanning Microsc 1995;9:587-596.
38. Kohjimoto Y, Ebisuno S, Tamura M, Ohkawa T: Interactions between calcium oxalate monohydrate crystals and Mardin-Darby canine kidney cells: Endocytosis and cell proliferation. Urol Res 1996;24:193-199.
39. Yamate T, Kohri K, Umekawa T, Amasaki N, Isikawa Y, Iguchi M, Kurita T: The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells. Eur Urol 1996;30:388-393.
40. Ettinger B, Tang A, Citron JT, Livermore B, Williams T: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315:1386-1389.
41. Faure M, Lissi EA, Vidella LA: Antioxidant capacity of allopurinol in biological systems. Biochem Int 1990;21:357-366.
42. - in posthypoxic injury of renal epithelial cells. Am J Physiol 1992;263:F251-F255.
43. Marotto ME, Thurman RG, Lemasters JJ: Early midzonal cell death during low-flow hypoxia in the isolated, perfused rat liver: Protection by allopurinol. Hepatology 1988;8:585-590.
44. Moorhouse PC, Grootveld M, Hallivell B, Quinland JG, Guttridge JMC: Allopurinol and oxipurinol are hydroxyl radical scavengers. FEBS Lett 1987;213:23-28.
45. Neve J: Physiological and nutritional importance of selenium. Experimentia 1991;47:187-193.
46. Nagunuma A, Satoh M, Imura N: Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with Ehrlich tumor cells. J Pharmacobiodyn 1984;7:217-220.
47. Strohmaier WL, Billes IC, Abelius A, Lahme S, Bichler KH: Selenium reduces high energy shock wave-induced renal injury in rats. Urol Res 2002;30:31-34.